Blog

SeerPharma Blog listing page

Webinar | Modern Lifecycle Process Validation: Beyond the Trilogy

September 30, 2025

Process Validation: A Universal Concept in the Regulatory Landscape

Across the pharmaceutical, biopharmaceutical and medical device industries, process validation has historically been structured around the trilogy:

  • Process Design: Develop and understand the process based on science, risk, and data (Stage 1)
  • Process Qualification: Confirm the...
Read More

SeerPharma at PDA APAC Aseptic Manufacturing Conference 2025

September 23, 2025

The PDA Aseptic Manufacturing Excellence Conference 2025 (13–14 October, Melbourne) will be a premier gathering for professionals shaping the future of aseptic manufacturing. The event will bring together regulators, industry leaders, and innovators to explore how organisations can align with evolving international standards while adopting new...

Read More

Master of GMP | Free Online Information Session | 7 Oct 2025

September 22, 2025

The Master of Good Manufacturing Practice from the University of Technology Sydney is your pathway to an industry-recognised qualification, whether you’re launching your career or stepping into a more senior role.

Read More

Computer Software Assurance (CSA): Smarter Validation Compliance

September 08, 2025

With the ever-evolving advancements of computerised systems and their involvements in the pharmaceutical, medical device, biotechnology and clinical trial industries, it is more critical than ever to ensure that these systems are appropriately assessed, validated and controlled. This is essential to safeguard the ensuing data integrity, product...

Read More

Webinar | AI in Life Sciences: Promise and Risk

September 03, 2025

Artificial Intelligence (AI) is reshaping industries worldwide, and life sciences is no exception. From drug discovery to clinical decision support, AI has the potential to transform the development, testing, and delivery of therapies. Yet, while the promise is immense, adoption remains cautious. The road ahead requires striking a balance between...

Read More

SeerPharma to Support 2025 Duke-NUS CoRE Training Workshop

September 02, 2025

Duke-NUS Medical School established the Centre of Regulatory Excellence (CoRE) over a decade ago to strengthen health product regulatory systems and capabilities across ASEAN and the wider Asia-Pacific region.

Read More

SeerPharma to Present on GMP at 2025 BioProcessing Network Conference

August 28, 2025

The pharmaceutical industry is experiencing rapid advances in biologics, with biopharmaceuticals delivering novel, targeted treatments that are transforming patient care. Across the Asia-Pacific region, leading organisations such as CSL, Pfizer, Biocon, Samsung Biologics, ThermoFisher, and WuXi, along with numerous small to medium-sized...

Read More

SeerPharma Supporting BioSymposium on Modernising Clinical Trials

August 25, 2025

For over 35 years, SeerPharma has been at the forefront of advancing Quality and GMP best practices within the pharmaceutical and medical device sectors. Our clients span the full product lifecycle—from early-stage clinical trials through to international market distribution.

Read More

Webinar | ICH E6 (R3) Data Governance & CSV: Changes-Impact-Compliance

August 22, 2025

The latest revision of ICH E6 (R3), finalised in January 2025 and enforced in Europe since 23 July 2025, marks a significant shift in clinical trial governance, moving beyond incremental updates to reflect modern trial practices and technologies. The guideline emphasises quality by design, risk-based proportionality, and clearer delineation of...

Read More

Webinar | Connecting the Dots: What Your Quality System Is Missing

August 04, 2025

Recurring deviations—especially those involving the same or similar issues—are often red flags for regulatory inspectors. In many cases, significant inspection deficiencies related to inadequate corrective actions could have been prevented if the organisation had recognised the patterns earlier and taken proactive steps.

Read More